Chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus.

J Res Med Sci 2013 May;18(5):438-41

Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Various forms of neuropathy are seen diabetic patients; chronic inflammatory demyelinating polyneuropathy (CIDP) seems not to be infrequent neuropathy in patients suffering from diabetes and it seems to be more common than in the general population; on the contrary, some authorities do not support pathogenetic association between diabetes mellitus (DM) and CIDP. Also, there are some controversies on the subject of CIDP treatment in diabetic patients. Some studies showed that patients with CIDP-DM considerably had recovered following treatment with immunotherapeutic modalities like (Intravenous immunoglobulin) IVIG and conversely, some else have argued against the prescription of IVIG in this group and recommend treatment with corticosteroids and provided that resistant, rituximab may be beneficial. The main limitation in most studies is the inadequate number of cases and as a result, problematic decision making in treatment. This article represents an inclusive review of diabetic CIDP presentation and treatment.

Download full-text PDF

Source
http://www.actaneurologica.be/acta/download/2007-1/03-Peders
Web Search
http://www.drrahiminejad.com/Files/MyDocuments/Image/2016751
Web Search
http://www.gbs-cidp.org/wp-content/uploads/2012/05/CIDP-Book
Web Search
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810582PMC
May 2013

Publication Analysis

Top Keywords

diabetic patients
8
inflammatory demyelinating
8
diabetes mellitus
8
chronic inflammatory
8
demyelinating polyneuropathy
8
treatment
5
immunoglobulin ivig
4
conversely argued
4
ivig conversely
4
argued prescription
4
group recommend
4
treatment corticosteroids
4
recommend treatment
4
intravenous immunoglobulin
4
ivig group
4
prescription ivig
4
recovered treatment
4
patients studies
4
treatment diabetic
4
cidp treatment
4

Similar Publications